Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Paul Kim, CFO and Treasurer of Fulgent Genetics, reports the withholding of shares to cover tax obligations arising from vesting restricted stock units.
Summary
- On October 26, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., had 2,738 shares of common stock withheld to satisfy tax obligations.
- The withholding was related to the vesting of restricted stock units granted on November 7, 2022.
- The price per share for the transaction was $19.42.
- Following the transaction, Kim directly owns 206,743 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine transaction related to tax obligations. It doesn't indicate positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and tax obligations, common for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 11/07/2022 | Date of grant of restricted stock units to the reporting person. |
| 11/09/2022 | Original report of the grant of restricted stock units on Form 4. |
| 10/26/2024 | Date of the stock transaction (tax withholding). |
| 10/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.